Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 1,3,4-Oxathiazol-2-one  



1.1  Molecular and electronic structure  





1.2  Synthesis  





1.3  Reactions  



1.3.1  Decarboxylation leading to isothiazole derivatives  





1.3.2  Other decarboxylation reactions  







1.4  Biological significance and applications  







2 See also  





3 References  














Oxathiazolones







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


1,3,4-Oxathiazol-2-one

1,3,4-Oxathiazol-2-one

Names
Preferred IUPAC name

2H-1,3,4-Oxathiazol-2-one

Identifiers

CAS Number

3D model (JSmol)

ChemSpider

PubChem CID

  • InChI=1S/C2HNO2S/c4-2-5-1-3-6-2/h1H

    Key: PJCFLHUCYONHAS-UHFFFAOYSA-N

  • InChI=1/C2HNO2S/c4-2-5-1-3-6-2/h1H

    Key: PJCFLHUCYONHAS-UHFFFAOYAS

  • O=C1OC=NS1

Properties

Chemical formula

C2HNO2S
Molar mass 103.10 g·mol−1

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Infobox references

The oxathiazolones are a family of heterocyclic compounds in which the parent derivative has the molecular formula C2HNO2S and for which multiple isomers are known. The two known isomers with the highest profile in the literature are 1,3,4-oxathiazol-2-one[1] and 1,4,2-oxathiazol-5-one.[2]

1,3,4-Oxathiazol-2-one[edit]

Molecular and electronic structure[edit]

1,3,4-Oxathiaol-2-one derivatives are planar heterocycles that prefer co-planarity with aromatic substituents.[3] It has been proposed that the π system of the ring consists of CNS and CO2 『π islands』that prefer coplanarity to enhance inter-ring π conjugation.[3]

Synthesis[edit]

The traditional route for 1,3,4-oxathiazol-2-one synthesis is via 1,3 dipolar cycloaddition, where chlorocarbonylsulfenyl chloride and amide are heated together in an appropriate solvent.[1] Appropriate solvents must dissolve the amide. Typically tolueneorchloroform is used. A wide variety of amides have been used is the synthesis of 1,3,4-oxathiazol-2-one yielding various derivatives. Variations in this procedure have included doing the reaction under an inert atmosphere, adding chlorocarbonylsulfenyl chloride drop-wise, and varying the ratio of chlorocarbonylsulfenyl chloride to amide. Variations in procedure may be due to local preferences or substituent effects.[citation needed]

Reactions[edit]

Decarboxylation leading to isothiazole derivatives[edit]

1,3,4-Oxathiazol-2-one derivatives are commonly used in thermal decarboxylation reactions to generate the corresponding derivative of the short-lived nitrile sulfide which may be trapped by 1,3-dipolar cycloaddition reactions to give heterocycles in low to high yields depending on the nature of the substituent groups.[4]

The intermediate can be trapped with a suitable electron deficient dipolariphile to give stable heterocycles such as isothiazole (seen below).

Other decarboxylation reactions[edit]

The intermediate has been successfully trapped using other dipolarophiles including nitriles, alkenes, and phosphaalkenes.

Some biologically significant 1,3,4-oxathiazol-2-one compounds (HT1171 and GL5[5]; bort(L)-oxathiazol-2-one[6]; HT2210 and HT2106[7].

Biological significance and applications[edit]

Some 1,3,4-oxathiazol-2-one heterocycles have demonstrated selective inhibition of proteasomesinMycobacterum tuberculosis and humans. Oxathiazolones HT1171 and GL5 (right) selectively inhibited the M. tuberculosis 26S proteasome and were over 1000-fold less effective on the human proteasome even in high concentrations.[5] Various 5‐styryl‐oxathiazol‐2‐one heterocycles have also been tested as anti-tubercular agents because of their ability to inhibit the M. tuberculosis 26S proteasome.[8]

ABortezomib derived 1,3,4-oxathiazol-2-one (bort(L)-oxathiazol-2-one, right) selectively acts against the human proteasome rather than bacterial proteasomes, much like Bortezomib.[6] HT2210 and HT2106 (right) were found to have similar effects.[7] Human proteasome inhibition is useful in the treatment of cancer, neurodegenerative disorders, and inflammation.[9]

See also[edit]

References[edit]

  1. ^ a b Jukič M, Grabrijan K, Kadić S, Lera Garrido FJ, Sosič I, Gobec S, Obreza A (December 2017). "Chlorocarbonylsulfenyl Chloride Cyclizations Towards Piperidin-3-yl-oxathiazol-2-ones as Potential Covalent Inhibitors of Threonine Proteases". Acta Chimica Slovenica. 64 (4): 771–781. doi:10.17344/acsi.2017.3883. PMID 29318298.
  • ^ Argyropoulos NG (1996-01-01). "4.14 - 1,4-Oxa/thia-2-azoles". In Katritzky AR, Rees CW, Scriven EF (eds.). Comprehensive Heterocyclic Chemistry II. Oxford: Pergamon. pp. 491–543. ISBN 978-0-08-096518-5. Retrieved 2020-10-11., and references therein.
  • ^ a b Krayushkin MM, Kalik MA, Vorontsova LG (2010-08-01). "The effect of the nature of the substituent on the structure of a 1,3,4-oxathiazol-2-one ring". Chemistry of Heterocyclic Compounds. 46 (4): 484–489. doi:10.1007/s10593-010-0535-9. S2CID 55033194.
  • ^ Marion C. McKie and R. Michael Paton (2002). "Synthesis of 5-acyl-1,2,4-thiadiazoles by cycloaddition of nitrile sulfides to acylcyanides". Arkivoc (vi): 15–21.
  • ^ a b Lin G, Li D, de Carvalho LP, Deng H, Tao H, Vogt G, et al. (October 2009). "Inhibitors selective for mycobacterial versus human proteasomes". Nature. 461 (7264): 621–6. Bibcode:2009Natur.461..621L. doi:10.1038/nature08357. PMC 3172082. PMID 19759536.
  • ^ a b Gryder BE, Guerrant W, Chen CH, Oyelere AK (2011). "Oxathiazole-2-one derivative of bortezomib: Synthesis, stability and proteasome inhibition activity". MedChemComm. 2 (11): 1083–1086. doi:10.1039/C1MD00208B.
  • ^ a b Fan H, Angelo NG, Warren JD, Nathan CF, Lin G (April 2014). "Oxathiazolones Selectively Inhibit the Human Immunoproteasome over the Constitutive Proteasome". ACS Medicinal Chemistry Letters. 5 (4): 405–10. doi:10.1021/ml400531d. PMC 4027612. PMID 24900849.
  • ^ Russo F, Gising J, Åkerbladh L, Roos AK, Naworyta A, Mowbray SL, et al. (June 2015). "Optimization and Evaluation of 5-Styryl-Oxathiazol-2-one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents". ChemistryOpen. 4 (3): 342–62. doi:10.1002/open.201500001. PMC 4522185. PMID 26246997.
  • ^ de Bettignies G, Coux O (November 2010). "Proteasome inhibitors: Dozens of molecules and still counting". Biochimie. 92 (11): 1530–45. doi:10.1016/j.biochi.2010.06.023. PMID 20615448.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Oxathiazolones&oldid=1154509036"

    Categories: 
    Oxygen heterocycles
    Sulfur heterocycles
    Nitrogen heterocycles
    Hidden categories: 
    Articles without EBI source
    Articles without KEGG source
    Articles without UNII source
    Articles containing unverified chemical infoboxes
    Chembox image size set
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from January 2021
     



    This page was last edited on 12 May 2023, at 23:48 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki